Fig. 11From: Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validationGraphical abstract for illustrating the role of BCA in repressing osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathwayBack to article page